NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-036-2010-1-GB-09 Compositions and Methods For Screening For Lyme Disease GB EP 11730110.1 Issued
NIDCR E-036-2010-1-CH-06 Compositions and Methods For Screening For Lyme Disease CH EP 11730110.1 Issued
NIDCR E-036-2010-1-EP-02 Compositions and Methods For Screening For Lyme Disease EP National Stage 11730110.1 Issued
NIA E-013-2010-0-JP-07 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS JP National Stage 2012-557260 Issued
NIA E-013-2010-0-AU-03 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS AU National Stage 2011224241 Issued
NIA E-013-2010-0-PCT-02 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS PCT PCT PCT/US2011/027988 Expired
NIDCR E-036-2010-1-PCT-01 Compositions and Methods For Screening Lyme Disease PCT PCT COMB PCT/US2011/027888 Expired
NIA E-013-2010-0-BR-04 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS BR National Stage BR112012022552-9 Issued
NIAID E-323-2005-3-AU-06 Influenza Hemagglutinin And Neuraminidase Variants AU DIV 2011201022 Abandoned
NCI E-003-2010-0-PCT-02 Immunogenic POTE Peptides And Methods of Use PCT PCT PCT/US2011/027577 Expired
NCI E-188-2004-0-AU-07 Nitric Oxide-Releasing Compounds And Uses Thereof AU DIV 2011200972 Abandoned
NCI E-094-1994-0-US-06 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 13/041,204 Abandoned
NIAID E-238-2008-2-US-03 Device And Method For Microwave assisted Cryo-sample Processing US National Stage 13/062,479 Abandoned
NIBIB E-078-2011-0-US-01 Optomechanics Module For Converting A Microscope To Provide Selective Plane Illumination Microscopy (SPIM) US 61/449,422 Abandoned
CC E-160-2011-0-US-01 System And Method For Automatic Initialization And Registration Of Navigation System US 61/448,714 Abandoned
NCI E-013-2002-0-US-08 Methods to Determine Immunogenicity of Humanized Anti-Tag 72 CC49 Antibodies US CON 13/039,171 8535890 Abandoned PDF
NIAID E-145-2004-3-US-03 Monoclonal Antibodies Against Orthopoxviruses US DIV 13/038,613 8404818 Issued PDF
NCI E-266-2009-0-PCT-02 Compositions and Methods For The Treatment of Cancer PCT PCT PCT/US2011/026727 Expired
NCI E-096-2011-0-US-01 Method of Selecting Cancer Patients For Anti-Angiogenesis Therapy US 61/448,092 Abandoned
NCI E-112-2011-0-US-01 Cervicovaginal Vaccination With Papillomavirus Pseudovirions For Protection Against Mucosatropic Infections US 61/447,499 Abandoned
NIAID E-147-2010-0-US-01 C-Abl Tyrosine Kinase Inhibitors Useful For Inhibiting Filovirus Replicationc US 61/447,298 Abandoned
NEI E-115-2010-0-PCT-02 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice PCT PCT PCT/IL2011/000193 Expired
NEI E-115-2010-0-EP-04 A3AR AGONISTS FOR THE TREATMENT OF UVEITIS EP National Stage 11710888.6 Pending
NEI E-115-2010-0-CA-05 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice CA National Stage 2790869 Abandoned
NEI E-115-2010-0-CN-06 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice CN National Stage 201180012191.8 Pending
NEI E-115-2010-0-MX-03 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice MX National Stage MX/0/2012/0/0006 Pending
NEI E-115-2010-0-IL-08 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice IL National Stage 221469 Pending
NEI E-115-2010-0-KR-07 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice KR National Stage 10-2012-7024527 Pending
NEI E-113-2010-0-CA-04 Nitisinone For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation CA National Stage 2791245 Issued
NIDDK E-116-2010-0-EP-03 Chrysophaentin Antimicrobial Compounds That Inhibit FtsZ Protein EP National Stage 11748136.6 Abandoned
NEI E-113-2010-0-EP-05 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation EP National Stage 11706137.4 Issued
NEI E-113-2010-0-AU-03 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation AU National Stage 2011220475 Issued
NEI E-056-2008-0-US-03 MIR 204, MIR 211, Their Anti-MIRS, And Therapeutic Uses of Same US National Stage 13/060,877 8455454 Issued PDF
NIAID E-263-2005-0-US-05 Targeting Poly-gamma-glutamic Acid To Treat Staphylococcus Edidermis And Related Infections US DIV 13/035,716 8252550 Issued PDF
NIDDK E-116-2010-0-PCT-02 Chrysophaentin Antimicrobial Compounds That Inhibit FtsZ Protein PCT PCT PCT/US2011/026220 Expired
NCI E-239-2009-0-PCT-02 DNA-Protein Vaccination Protocols PCT PCT PCT/US2011/026325 Expired
NEI E-113-2010-0-PCT-02 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation PCT PCT PCT/US2011/026260 Expired
NCI E-159-2011-0-US-01 Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling US 61/446,716 Abandoned
NIDDK E-115-2011-0-US-01 Chrysophaentin Analogs That Inhibit FTSZ Protein US 61/446,978 Abandoned
NCI E-097-2010-0-AU-03 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof AU National Stage 2011223937 Abandoned
NCI E-097-2010-0-EP-05 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof EP National Stage 11706722.3 Abandoned
NCI E-097-2010-0-DE-07 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof DE EP 11706722.3 Abandoned
NCI E-097-2010-0-FR-08 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof FR EP 11706722.3 Abandoned
NCI E-097-2010-0-GB-09 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof GB EP 11706722.3 Abandoned
NCI E-097-2010-0-PCT-02 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof PCT PCT PCT/US2011/026086 Expired
NCI E-097-2010-0-CA-04 Gene Sets For Detection of UltraViolet A Exposure And Methods of Use Thereof CA National Stage 2791662 Abandoned
NCI E-055-2013-0-US-01 COMBINED CELL BASED GP96-IG-SIV/HIV, RECOMBINANT GP120 PROTEIN VACCINATION FOR PROTECTION FROM SIV/HIV US 61/445,884 Abandoned
NIDDK E-102-2011-0-CA-08 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES CA National Stage 2789259 Issued
NHLBI E-251-2009-0-GB-08 Azicon Beam Polarization Devices GB EP 11706440.2 Issued
NHLBI E-251-2009-0-CH-05 Azicon Beam Polarization Devices CH EP 11706440.2 Issued